ASHENEWS reports that the National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert over the circulation of two counterfeit batches of Avastin 400mg/16ml, an anticancer medication manufactured by Roche Diagnostics GmbH, Germany.
Trending
- Nigeria’s FX market hits record $4.4bn turnover amid surge in mystery deals
- How fictitious PFIPC gained government’s recognition – AGF
- Urhoghide calls for collaboration to protect Nigeria’s fibre infrastructure
- Abuja GSM market enhances security to curb stolen phones
- FG launches harmonized HR modules to strengthen civil service
- MWAN urges integration of mental health into primary care
- ACF trains Gella residents on climate-smart agriculture
- Kwara NMA calls for stronger healthcare reforms
